Premium
HLA‐DRB1*03 is a susceptibility gene in patients with Graves’ disease with and without ophthalmopathy
Author(s) -
Yarman S.,
Oguz F.,
Carin M.
Publication year - 2007
Publication title -
international journal of immunogenetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 47
eISSN - 1744-313X
pISSN - 1744-3121
DOI - 10.1111/j.1744-313x.2006.00644.x
Subject(s) - graves' ophthalmopathy , human leukocyte antigen , medicine , polymerase chain reaction , graves' disease , hla drb1 , gastroenterology , disease , immunology , gene , antigen , biology , genetics
Summary We sought an association between certain human leucocyte antigen (HLA) markers and Graves’ disease (GD) with and without ophthalmopathy (OP). One hundred and thirty‐one Turkish patients with GD (50 without OP, 81 with OP) and 250 local healthy controls were studied. HLA‐DRB1 typing was performed by using polymerase chain reaction–sequence‐specific primers (PCR‐SSP) method. The frequencies of DRB1*03 was significantly increased in GD compared to controls (OR = 2.07; 95% CI = 1.24–3.44), whereas DRB1*13 (OR = 0.33; 95% CI = 0.18–0.61) and DRB1*07 (OR = 0.31; 95% CI = 0.13–0.70) were significantly increased in controls compared to patients. None of the three associations showed any specificity to the OP group.